APA
ABEO icon

American Portfolios Advisors’s Abeona Therapeutics ABEO Stock Holding History

American Portfolios Advisors’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-40
Closed -$12.8K – 2401
2018
Q3 		$12.8K Buy
40
+20
+100% +$7.09K ﹤0.01% 1653
2018
Q2 		$8K Hold
20
– – ﹤0.01% 1808
2018
Q1 		$7.17K Hold
20
– – ﹤0.01% 1743
2017
Q4 		$7.92K Buy
+20
New +$8.27K ﹤0.01% 1644

Other funds holding ABEO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

American Portfolios Advisors's ABEO Position: Q4 2018 in Review

American Portfolios Advisors sold out of Abeona Therapeutics (ABEO) in Q4 2018, closing a stake of 40 shares — an estimated $12.8K sold.

American Portfolios Advisors first reported a position in ABEO in Q4 2017 and held it in 4 quarters. The position peaked at $12.8K in Q3 2018. 99 funds tracked by Wall St. Rank hold ABEO as of Q4 2018.

  • American Portfolios Advisors reported no remaining Abeona Therapeutics position as of Q4 2018 after selling out during the quarter.
  • American Portfolios Advisors sold 40 Abeona Therapeutics shares in Q4 2018, an estimated $12.8K.
  • American Portfolios Advisors first reported a position in Abeona Therapeutics in Q4 2017 and held it in 4 quarters.
  • American Portfolios Advisors's Abeona Therapeutics position peaked at $12.8K in Q3 2018.
  • 99 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2018.

Based on American Portfolios Advisors's 13F filing for Q4 2018, filed 24 Mar 2023.